Need for a paradigm shift in soil-transmitted helminthiasis control: Targeting the right people, in the right place, and with the right drug(s).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Implications of global health funding patterns for implementation of a novel soil-transmitted helminth and lymphatic filariasis medicine: Ivermectin/albendazole fixed-dose combination.PLoS neglected tropical diseases · 2026
   Review
2. Inequitable access to medicines for neglected tropical diseases in Europe: health system vulnerabilities and a call for coordinated action.The Lancet regional health. Europe · 2026
   Review
3. Geostatistical analysis to guide treatment decisions for soil-transmitted helminthiasis control in Uganda.PLoS neglected tropical diseases · 2025
   Article
4. The changing neglected tropical disease landscape in Africa: implications for policy, practice, and strengthening health systems.Health affairs scholar · 2025
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

20 authors.

Funding

Abstract

PubMed holds no abstract for this paper.